Order Article Reprints

Chong WC, Jayasekara WSN, Vaghjiani VG, Parackal S, Sun C, Popovski D, Algar EM, Firestein R, Wood PJ, Khan S, et al. Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy. Cancers. 2021; 13(20):5145. https://doi.org/10.3390/cancers13205145

Chong, Wai C., W. Samantha N. Jayasekara, Vijesh G. Vaghjiani, Sarah Parackal, Claire Sun, Dean Popovski, Elizabeth M. Algar, Ron Firestein, Paul J. Wood, Sara Khan, and et al. 2021. "Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy" Cancers 13, no. 20: 5145. https://doi.org/10.3390/cancers13205145

Chong, W. C., Jayasekara, W. S. N., Vaghjiani, V. G., Parackal, S., Sun, C., Popovski, D., Algar, E. M., Firestein, R., Wood, P. J., Khan, S., Huang, A., Ashley, D. M., Downie, P., & Cain, J. E. (2021). Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy. Cancers, 13(20), 5145. https://doi.org/10.3390/cancers13205145